9 - Subgroup Analyses of Kte-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Adult Patients (Pts) with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in Zuma-3

Autor: Shah, Bijal D., Cassaday, Ryan D., Park, Jae H., Houot, Roch, Oluwole, Olalekan O., Logan, Aaron C., Boissel, Nicolas, Leguay, Thibaut, Bishop, Michael R., Topp, Max S., Tzachanis, Dimitrios, O’Dwyer, Kristen M., Arellano, Martha L., Lin, Yi, Baer, Maria R., Schiller, Gary J., Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C., Wierda, William G., DeAngelo, Daniel J., Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra C., Masouleh, Behzad Kharabi, Ghobadi, Armin
Zdroj: In Transplantation and Cellular Therapy February 2023 29(2) Supplement:S7-S8
Databáze: ScienceDirect
Externí odkaz: